Font Size: a A A
Keyword [Prognosis factor]
Result: 21 - 40 | Page: 2 of 4
21. Clinical Analysis Of Spinal Metastatic Tumor
22. APE1 And VEGF Expression And Their Correlation With Prognosis In Non-small Cell Lung Cancer
23. Survival Analysis Of 109 Patients With Metastatic Colorectal Cancer Treated By Third-line Therapy
24. Late Preterm Infants With Respiratory Failure Respiratory Support Efficacy And Outcome Of Observation And Prognostic Analysis
25. The Clinical Study And Mechanistic Exploration Of BCL11A In Myeloid Leukemia
26. Verification And Exploration Of Prognostic Factors For Triple-Negative Breast Cancer
27. Pre-operative Neutrophil Lymphocyte Ratio As A Prognostic Factor In Endometrioid Endometrial Adenocarcinoma
28. Clinical Retrospective Analysis Of38Malignant Ovarian Germ Cell Tumors
29. The Impact Of Hypertensive Intracerebral Hemorrhage Craniotomy Prognostic Factors
30. Clinical Characteristic And The Mechanism Of Patients With Brain Metastases As First Symptom Of Lung Cancer
31. Correlation Between Lymph Node Metastasis And Clinico-pathological Parameters In Early Gastric Cancer And Prognosis Analysis Of Lymph Node Metastasis In Early Gastric Cancer Cases
32. Clinical Characteristics And Prognosis Factor Analysisof 62 Cases With Hemophagocytic Syndrome
33. Comparative Study Of Different Treatment Modalities For Limited-stage Small Cell Lung Cancer
34. Expression And Prognostic Significance Of APE1/Ref-1 And NPM1 Proteins In High-Grade Ovarian Serous Adenocarcinoma
35. Analysis Of The Factors That Affect The Clinical Outcomes Of Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator
36. Analysis Of Prognosis Factors Of Sudden Sensorineural Hearing Loss
37. Analysis Of Curative Effect And Prognosis Of Primary Tumor Resection And Chemotherapy Alone In Patients With Unresectable Liver Metastases Of Colorectal Cancer
38. The Cox Regression Analysis Of The Cutaneous Malignant Melanoma Prognostic Factor
39. Prognostic Significance Of The Ratio Of Neutrophil To Lymphocyte In Breast Cancer
40. The 3DCRT Surival Benefit Evaluation Of Hepatocellular Carcinoma Patients
  <<First  <Prev  Next>  Last>>  Jump to